increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6
and-17, interferon-γ and associated downstream pathways. Comparison of two poles of MS
pathology—acute lesions with inflammation versus' silent'lesions without inflammation—
revealed differentially transcribed genes. Some products of these genes were chosen as
targets for therapy of experimental autoimmune encephalomyelitis (EAE) in mice …